Immunoprevention. Definition By using immunological agents to construct, improve or inhibit immune...
-
Upload
toby-roberts -
Category
Documents
-
view
215 -
download
2
Transcript of Immunoprevention. Definition By using immunological agents to construct, improve or inhibit immune...
Immunoprevention
Definition
By using immunological agents to
construct, improve or inhibit immune
response, people can prevent some
diseases.
Artificial immunization (active and passive)
Development of new vaccines
Application of vaccines
Active Immunization
Passive Immunization
Administration of an antigen (usually as a modified infectious agent or toxin)
Administration of antibody, or antibody-contained serum for passive protection of the host
Acquisitions of active and passive immunity
Active Immunization
Elicit protective immunity: Ab, cellular
responses
Elicit immunologic memory
Methods: natural infection, vaccines
Principles of active Immunization
Basic features of vaccine
SafeEffective Practical
Types of vaccines
1.Attenuated organisms (Measles)
2.Inactivated organisms (Hepatitis A
vaccine)
3.Toxoid (Diphtheria, Tetanus)
Whole organisms
Some conditions should not use active immunization
1. Fever2. Severe heart disease3. Acute transmitted infection4. Cancer5. Kidney disease6. TB infection7. Grave’s disease8. Diabetes 9. Immunodeficiency disease
Passive Immunization
Transfer of preformed antibodiesThe protection is transientNo memory response
There are some conditions that warrant the use of passive immunization
Deficiency of antibody synthesis
Exposure or likely exposure to a disease that
will cause complications
Infection by pathogens whose effects may be
ameliorated by antibody
Weakness of passive immunization
1. Isotypic determinants of the foreign antibody (IgE
production)
2.Formation of immune complex (IgG, IgM)
3.Anti-allotype responses
Planned Immunization
Childhood immunizations have already been a part of routine health care.
Planned Immunization Schedule in China (1)Age Type of vaccines
Primary Immunization
Birth BCG vaccine, Hepatitis B virus vaccine (1 st)
1 month Hepatitis B virus vaccine (2 nd)
2 months Poliovirus vaccine ( 1st)
3 months Poliovirus vaccine ( 2nd), DTP (1st)
4 months Poliovirus vaccine (3rd), DTP (2nd)
5 months DTP (3rd)
6 months Hepatitis B virus vaccine (3rd),Meningococcal polysaccharide vaccine
8 months Measles virus vaccine
1 year Japanese encephalitis vaccine (1st and 2nd)
Planned Immunization Schedule in China (2)
Age Type of vaccines
“Booster” /reimmunization
1.5 years DTP, Measles virus vaccine, poliovirus vaccine, Meningococcal polysaccharide vaccine
2 years Japanese encephalitis vaccine
3 years Japanese encephalitis vaccine
4 years Poliovirus vaccine
5 years DTP, Measles virus vaccine, BCG vaccine, Japanese encephalitis vaccine
Development of new vaccines
Subunit vaccines
Conjugate vaccines
Synthetic peptide vaccines
Recombinant vector vaccines
Gene-engineering vaccines
DNA vaccines
Transgenic plant vaccines
Subunit vaccines
The current vaccine for Streptococcus pneumoniae, which causes pneumococcal pneumonia, consists of 23 antigenically different capsular polysaccharides. The vaccine induces formation of opsonizing antibodies and is now on the list of vaccines recommended for all infants.
The vaccine for Neisseria meningitidis, a common cause of bacterial meningitis, also consists of purified capsular polysaccharides.
One limitation of polysaccharide vaccines is their inability to activate Th cells.
Involve Th cells directly in the response to a polysaccharide antigen
conjugate the antigen to some sort of protein carrier.
For example, the vaccine for Haemophilus influenzae type b (Hib), the major cause of bacterial meningitis in children less than 5 years of age, consists of type b capsular polysaccharide covalently linked to a protein carrier, tetanus toxoid.
Conjugated vaccines
Synthetic peptide vaccines
The use of synthetic peptides as vaccines has not progressed as originally projected.
Peptides are not as immunogenic as proteins, and it is difficult to elicit both humoral and cellular immunity to them
Multivalent Vaccines
Recombinant vector vaccines
Genes that encode major antigens of specially virulent pathogens can be introduced into attenuated viruses or bacteria.The attenuated organism serves as a vector, replicating within the host and expressing the gene product of the pathogen.
Salmonellatyphimurium
Recombinant adenovirus for tumor
Genetic engineering vaccines
Theoretically, the gene encoding any immunogenic protein can be cloned and expressed in bacterial, yeast, or mammalian cells using recombinant DNA technology.
This vaccine was developed by cloning the gene for the major surface antigen of hepatitis B virus (HBsAg) and expressing it in yeast cells.
Plasmid DNA encoding a protein antigen from a pathogen can serve as an effective vaccine inducing both humoral and cell-mediated immunity.
DNA vaccines
DNA vaccines induce humoral and cellular immunity
DNA vaccines induce humoral and cellular immunity
Transgenic plant vaccines
Application of vaccines
1. Prevention of infectious disease
2. Prevention of tumor
3. Others (Prevention of conception,
treatment of drug dependency)
Review questions1. What are the advantages and disadvantages of using attenuated organisms as vaccines?
2. A young girl who had never been immunized to tetanus stepped on a rusty nail and got a deep puncture wound. The doctor cleaned out the wound and gave the child an injection of tetanus antitoxin. a. Why was antitoxin given instead of a booster shot of tetanus toxoid? b. If the girl receives no further treatment and steps on a rusty nail again 3 years later, will she be immune to tetanus?